First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab

We report the first case of coronavirus disease 2019 (COVID-19) in a multiple myeloma patient successfully treated with tocilizumab. Although tocilizumab was effective in the treatment of COVID-19 in this case, randomized controlled trials are needed.

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Blood Adv
Egile Nagusiak: Zhang, Xuhan, Song, Kaidi, Tong, Fei, Fei, Mingming, Guo, Hui, Lu, Zhaohui, Wang, Jinquan, Zheng, Changcheng
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2020
Gaiak:
Exceptional Case Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7160284/
https://ncbi.nlm.nih.gov/pubmed/32243501
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001907
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak